Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine

SIMPLE SUMMARY: Despite the increased use of neoadjuvant chemotherapy in the early setting of breast cancer, there is a clinical need for predictive markers of response in daily practice. In the era of precision medicine and personalized treatment, new predictive markers that enable the better selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Derouane, Françoise, van Marcke, Cédric, Berlière, Martine, Gerday, Amandine, Fellah, Latifa, Leconte, Isabelle, Van Bockstal, Mieke R., Galant, Christine, Corbet, Cyril, Duhoux, Francois P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405974/
https://www.ncbi.nlm.nih.gov/pubmed/36010869
http://dx.doi.org/10.3390/cancers14163876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405974/
https://www.ncbi.nlm.nih.gov/pubmed/36010869
http://dx.doi.org/10.3390/cancers14163876

Ejemplares similares